|
|
|
|
07.15-08.00 |
Meet the Expert 1:Macroprolactinaemia |
| |
|
CLYDE AUDITORIUM |
| |
|
Chair: TBA |
| |
|
P Chanson (Paris, France) |
| |
|
|
| |
07.15-08.00 |
Meet the Expert 2:Gestational diabetes |
| |
|
LOMOND AUDITORIUM |
| |
|
Chair: D Johnston (London, UK) |
| |
|
R Corcoy (Barcelona, Spain) |
| |
|
|
| |
07.15-08.00 |
Meet the Expert 3:Chips, arrays and biosensors: |
| |
|
HALL 1 |
| |
|
Chair: V Pirags (Riga, Latvia) |
| |
|
A Turner (Cranfield, UK) |
| |
|
|
| |
07.15-08.00 |
Meet the Expert 4:Cell immortalisation in
endocrine |
| |
|
FORTH ROOM |
| |
|
Chair: TBA |
| |
|
S Kim (London, UK) |
| |
|
|
| |
08.10-10.10 |
Symposium 1:Thyroid and the heart |
| |
|
Thyroid and the heart |
| |
|
CLYDE AUDITORIUM |
| |
|
Chairs: A Tsatsoulis (Ioannina, Greece) & |
| |
|
J Franklyn (Birmingham, UK) |
S11 |
08.10 |
Cardiac
repercussions of thyroid hormones |
| |
|
J Franklyn (Birmingham, UK) |
S12 |
08.40 |
The
assessment of cardiovascular risk factors in thyroid disease |
| |
|
B Biondi (Naples, Italy) |
S13 |
09.10 |
Iodothyronamines:
rapid-acting thyroid hormone metabolites |
| |
|
T Scanlan (San Francisco, USA) |
S14 |
09.40 |
Role
of thyroid hormone receptor isoforms in development and function
of heart and other tissues |
| |
|
J Samarut (Lyon, France) |
| |
|
|
| |
08.10-10.10 |
Symposium 2:The endocrinology of psychiatric |
| |
|
LOMOND AUDITORIUM |
| |
|
Chair: P Bouloux (London, UK) |
S15 |
08.10 |
Glucocorticoids,
enzymes and memory impairments with ageing |
| |
|
J Seckl (Edinburgh, UK) |
S16 |
08.40 |
Effects
of hypothyroidism on brain metabolism and its associations with
neuropsychiatric impairments |
| |
|
M Bauer (Berlin, Germany) |
S17 |
09.10 |
Overview
of neuroendocrine side-effects |
| |
|
R Tandon (Ann Arbor, USA) |
S18 |
09.40 |
Endocrinology
of post-traumatic stress |
| |
|
C Kirshbaum (Dresden, Germany) |
| |
|
|
| |
08.10-10.10 |
Clinical Management Workshop 1:Green over-the-counter |
| |
|
HALL 1 |
| |
|
Chair: R Sharpe (Edinburgh, UK) |
S75 |
08.10 |
Regulation
of steroid receptor expression and proliferation in prostate cancer
by genistein and other flavonoids |
| |
|
H Klocker (Innsbruck, Austria) |
S76 |
08.40 |
Soy,
flavonoids and osteoporosis |
| |
|
E Lydeking-Olsen (Copenhagen, Denmark) |
S77 |
09.10 |
Aftermath
of WHI: the risks or benefits of red clover and soy extracts in
postmenopausal OTC HRT |
| |
|
W Wuttke (Göttingen, Germany) |
| |
|
|
| |
08.10-10.10 |
Oral Communications 1:Signal transduction |
| |
|
ALSH ROOM |
| |
|
Chairs: M Tena Sempere (Cordoba, Spain) & |
| |
|
W Knepel (Göttingen, Germany) |
OC1* |
08.10 |
Stress
response after TIF-2 disruption: loss of grip on feedback control
or adrenocortical impairment? |
| |
|
AV Patchev, D Fischer, M Herkenham, F Götz,
SS Wolf, M Gehin, P Chambon, VK Patchev & OFX Almeida |
OC2* |
08.25 |
Signalling
and internalisation characteristics of corticotropin-releasing
hormone (CRH) receptors |
| |
|
D Markovic & D Grammatopoulos |
OC3 |
08.40 |
Activation
of cyclic AMP (cAMP) binding protein (CREB) by gonadotrophinreleasing
hormone (GnRH) requires calcium influx and PKC activity in gonadotroph
cell lines |
| |
|
KC Jonas, IA Thompson, JM Burrin & RC Fowkes |
OC4 |
08.55 |
The
role of MRAP in the functional expression of the melanocortin 2
receptor |
| |
|
SN Cooray, JP Chapple, LA Metherell, ME Cheetham & AJL
Clark |
OC5 |
09.10 |
The
overexpression Pit-1 pathway, switch on by Ret, get into apoptosis
fate |
| |
|
C Cañibano, N Rodriguez,
M Garcia-Lavancleira, A
Viclal , MG Borrello,C Diéguez C, CN Alvaicz |
OC6 |
09.25 |
Activation
of androgen membrane binding sites induces potent regression of
prostate cancer cells in vitro and in vivo |
| |
|
N Papadopoulou, M Kampa, A Gravanis, E Castanas & C
Stournaras |
OC7 |
09.40 |
The
effect of bone marrow stem cell (BMSC) differentiation on growth
hormone receptor (GHR)-associated signalling pathways |
| |
|
MD Lewis, TE Easter, C Elford, ME Ludgate, BAJ
Evans, DA Rees & MF Scanlon |
OC8 |
09.55 |
Role
of the calcium-calmodulin dependent kinase II in oncogenic ras-induced
proliferation |
| |
|
AL Cavallo, M Illario, E Di Vito, S Monaco,
G Fenzi, G Rossi & M Vitale |
| |
|
|
| |
08.10-10.10 |
Young Endocrinologists Session:Presenting
your research - Presenting your research - getting your work known |
| |
|
FORTH ROOM |
| |
|
Chair: W Arlt (Birmingham, UK) |
S102 |
08.10 |
Giving
talks |
| |
|
A McNeilly (Edinburgh, UK) |
S103 |
08.35 |
Practical
tips for a perfect poster |
| |
|
A Mostyn (Nottingham, UK) |
S104 |
09.00 |
Papers
for peer-reviewed journals |
| |
|
S Pearce (Newcastle upon Tyne, UK) |
S105 |
09.25 |
PhD/MD
thesis: a recipe for success |
| |
|
D Abayasekara (London, UK) |
S106 |
09.50 |
Talking
to a lay audience |
| |
|
T Parkhill (Bristol, UK) |
| |
|
|
| |
10.10-10.40 |
COFFEE |
| |
|
HALL 3 |
| |
|
|
| |
10.40-11.25 |
Society for Endocrinology Transatlantic
Medal Lecture |
| |
|
CLYDE AUDITORIUM |
| |
|
Chair: J Wass (Oxford, UK) |
S3 |
10:40 |
Nuclear
receptors and transcriptional control of lipid metabolism |
| |
|
D Mangelsdorf (Dallas, USA) |
| |
|
|
| |
11.35-12.20 |
Meet the Expert 1:Macroprolactinaemia |
| |
|
CLYDE AUDITORIUM |
| |
|
Chair: TBA |
| |
|
P Chanson (Paris, France) |
| |
|
|
| |
11.35-12.20 |
Meet the Expert 2:Gestational diabetes |
| |
|
Gestational diabetes |
| |
|
LOMOND AUDITORIUM |
| |
|
Chair: D Johnston (London, UK) |
| |
|
R Corcoy (Barcelona, Spain) |
| |
|
|
| |
11.35-12.20 |
Meet the Expert 3:Chips, arrays and biosensors: |
| |
|
Chips, arrays and biosensors: bioinformatics in
endocrine research |
| |
|
HALL 1 |
| |
|
Chair: V Pirags (Riga, Latvia) |
| |
|
A Turner (Cranfield, UK) |
| |
|
|
| |
11.35-12.20 |
Meet the Expert 4:Cell immortalisation in |
| |
|
Cell immortalisation in endocrine research |
| |
|
FORTH ROOM |
| |
|
Chair: TBA |
| |
|
S Kim (London, UK) |
| |
|
|
| |
12.20-13.50 |
Novartis
Pharmaceuticals Satellite Symposium: From controversy to clarity
in acromegaly management (PDF) (62kb) |
| |
|
FORTH ROOM |
| |
|
|
| |
13.50-14.50 |
POSTERS AND LUNCH |
| |
|
HALL 3 |
| |
|
|
| |
14.50-16.50 |
Symposium 3:Cancer and the skeleton |
| |
|
CLYDE AUDITORIUM |
| |
|
Chair: L Gennari (Sienna, Italy) |
S19 |
14.50 |
Mechanisms
of malignant hypercalcaemia |
| |
|
P Clezardin (Lyon, France) |
S20 |
15.20 |
The
management of malignant hypercalcaemia |
| |
|
P Selby (Manchester, UK) |
S21 |
15.50 |
Oncogenic
osteomalacia: novel insights into the regulation of phosphate homeostasis |
| |
|
H Jueppner (Boston, USA) |
S22 |
16.20 |
Why
does thyroid carcinoma metastasise to bone? |
| |
|
J Smit (Leiden, The Netherlands) |
| |
|
|
| |
14.50-16.50 |
Symposium 4:Cannabinoid signalling |
| |
|
LOMOND AUDITORIUM |
| |
|
Chairs: C Tsigos (Athens, Greece) & |
| |
|
M Korbonitz (London, UK) |
S23 |
14.50 |
Cannabinoids
as modulators of neuroendocrine signalling |
| |
|
U Pagotto (Bologna, Italy) |
S24 |
15.30 |
Cannabinoids
and feeding behaviour |
| |
|
T Kirkham (Liverpool, UK) |
S25 |
16.10 |
Clinical
applications of manipulation of cannabinoid receptors (agonists) |
| |
|
R Ross (Aberdeen, UK) |
| |
|
|
| |
14.50-16.50 |
Clinical Management Workshop 2:Management
of complex genital |
| |
|
Management of complex genital anomalies and the
transition from childhood to adulthood |
| |
|
FORTH ROOM |
| |
|
Chair: A Grüters-Kieslich (Berlin, Germany) |
S78 |
14.50 |
Management
of the infant with ambiguous external genitalia. The pediatric
endocrinologist's approach |
| |
|
C Dacou-Voutetakis (Athens, Greece) |
S79 |
15.30 |
Surgical
management of ambiguous genitalia in the infant |
| |
|
C N Fékété (Paris, France) |
S80 |
16.10 |
Management
of complex genital anomalies and the transition from childhood
to adulthood: a patient's perspective |
| |
|
P Carmichael (London, UK) |
| |
|
|
| |
14.50-16.50 |
Oral Communications 2:Steroids and reproductive |
| |
|
Steroids and reproductive endocrinology |
| |
|
HALL 1 |
| |
|
Chair: I Huhtaniemi (London, UK) |
OC9 |
14.50 |
11b
HSD1: anti-inflammatory mechanism in acute and chronic inflammation? |
| |
|
AE Coutinho, M Gray, DA Sawatzky, D Brownstein,
J Mullins, JR Seckl, JS Savill & KE Chapman |
OC10* |
15.05 |
Progesterone
signaling in human myometrium is mediated through two novel membrane
G protein-coupled receptors |
| |
|
E Karteris, S Zervou, Y Pang, J Dong, EW Hillhouse,
HS Randeva & P Thomas |
OC11 |
15.20 |
The
adrenal X-zone is involved in progesterone inactivation |
| |
|
F Beuschlein, L Heshkovitz, S Klammer, U Lichtenauer,
I Shapiro, M Krup & Y Weinstein |
OC12 |
15.35 |
Expression
profiling of genes in the testis of rhesus macaques during development
and aging |
| |
|
HF Urbanski, VT Garyfallou, DR Lemos, JL Downs & DI
Brown |
OC13 |
15.50 |
Anti-mullerian
hormone (AMH) production by granulosa cells from anovulatory PCO
is 100 times higher than from normal ovaries, but is inhibited
by metformin |
| |
|
L Pellatt, L Hanna, D Feldman, P Malloy, H Brain,
S Whitehead & H Mason |
OC14 |
16.05 |
Endometrial
intracrinology: expression of 3b-hydroxysteroid dehydrogenase (3bHSD),
and 17b-hydroxysteroid dehydrogenase type 5 (17bHSD-5) |
| |
|
SE McDonald, JI Mason & HOD Critchley |
OC15 |
16.20 |
Role
of the Hu proteins, HuR and HuD, and aCP1 in the regulation of
androgen receptor expression and activity in prostate cancer cells |
| |
|
CF Down, RR Lareu, B Granath, DJ Beveridge,
H Furneaux, J Bentel & PJ Leedman |
OC16 |
16.35 |
17b-estradiol
regulates pituitary AnxA1 expression and externalization in vivo
and in vitro |
| |
|
EL Davies, HC Christian, S Omer, JC Buckingham & JF
Morris |
| |
|
|
| |
16.50-17.30 |
TEA |
| |
|
HALL 3 |
| |
|
|
| |
17.30-18.15 |
Plenary 1 |
| |
|
CLYDE AUDITORIUM |
| |
|
Chair: S Webb (Barcelona, Spain) |
S8 |
17:30 |
Vitamin
D action |
| |
|
R Bouillon (Leuven, Belgium) |
| |
|
|
| |
18.30-20.00 |
Ipsen Satellite Symposium |
| |
|
Tailoring therapies for patients with endocrine
disorders |
| |
|
CLYDE AUDITORIUM |
| |
|
|
| |
From 19.00 |
The Sunday Social |
| |
|
TIGER TIGER |
